Published in J Head Trauma Rehabil on November 04, 2015
Genetic variation and dopamine D2 receptor availability: a systematic review and meta-analysis of human in vivo molecular imaging studies. Transl Psychiatry (2016) 0.80
COMT and ANKK1 Genetics Interact With Depression to Influence Behavior Following Severe TBI: An Initial Assessment. Neurorehabil Neural Repair (2016) 0.79
Persistent Hypogonadotropic Hypogonadism in Men After Severe Traumatic Brain Injury: Temporal Hormone Profiles and Outcome Prediction. J Head Trauma Rehabil (2016) 0.78
Catecholamines and cognition after traumatic brain injury. Brain (2016) 0.78
Effects of Depression and Antidepressant Use on Cognitive Deficits and Functional Cognition Following Severe Traumatic Brain Injury. J Head Trauma Rehabil (2016) 0.76
Preliminary Associations Between Brain-Derived Neurotrophic Factor, Memory Impairment, Functional Cognition, and Depressive Symptoms Following Severe TBI. Neurorehabil Neural Repair (2015) 0.76
Applying Systems Biology Methodology To Identify Genetic Factors Possibly Associated with Recovery after Traumatic Brain Injury. J Neurotrauma (2017) 0.75
TBI Rehabilomics Research: an Exemplar of a Biomarker-Based Approach to Precision Care for Populations with Disability. Curr Neurol Neurosci Rep (2017) 0.75
Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23
Assessment of outcome after severe brain damage. Lancet (1975) 27.39
Assessing the impact of population stratification on genetic association studies. Nat Genet (2004) 16.28
Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet (2003) 4.63
The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry (2007) 4.51
Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biol Psychiatry (2011) 3.78
A validation of the functional independence measurement and its performance among rehabilitation inpatients. Arch Phys Med Rehabil (1993) 3.26
Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat (2004) 2.89
Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci U S A (2007) 2.62
Traumatic brain injury in the elderly: increased mortality and worse functional outcome at discharge despite lower injury severity. J Trauma (2002) 2.29
D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics (1997) 2.28
Validity of the Patient Health Questionnaire-9 in assessing depression following traumatic brain injury. J Head Trauma Rehabil (2005) 1.92
Neuropsychological predictors of driving errors in older adults. J Am Geriatr Soc (2010) 1.67
Do somatic and cognitive symptoms of traumatic brain injury confound depression screening? Arch Phys Med Rehabil (2011) 1.64
Functional recovery after moderate/severe traumatic brain injury: a role for cognitive reserve? Neurology (2014) 1.60
Molecular heterosis: a review. Mol Genet Metab (2000) 1.59
Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457. J Neurosci (2005) 1.58
Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis. Neurosci Biobehav Rev (2009) 1.57
Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case-control studies and evidence of publication bias. Mol Psychiatry (2007) 1.56
Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor. EMBO J (2007) 1.44
Traumatic brain injury in aged animals increases lesion size and chronically alters microglial/macrophage classical and alternative activation states. Neurobiol Aging (2012) 1.41
Detrimental effects of aging on outcome from traumatic brain injury: a behavioral, magnetic resonance imaging, and histological study in mice. J Neurotrauma (2008) 1.29
Acute predictors of successful return to work 1 year after traumatic brain injury: a multicenter analysis. Arch Phys Med Rehabil (1997) 1.25
The A1 allele of the human D2 dopamine receptor gene is associated with increased activity of striatal L-amino acid decarboxylase in healthy subjects. Pharmacogenet Genomics (2005) 1.19
Relationships between cerebrospinal fluid markers of excitotoxicity, ischemia, and oxidative damage after severe TBI: the impact of gender, age, and hypothermia. J Neurotrauma (2004) 1.13
Impaired dopaminergic neurotransmission in patients with traumatic brain injury: a SPECT study using 123I-beta-CIT and 123I-IBZM. Eur J Nucl Med (2000) 1.11
The DRD2 gene 957C>T polymorphism is associated with posttraumatic stress disorder in war veterans. Depress Anxiety (2009) 1.03
Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial. Am J Phys Med Rehabil (2004) 1.02
DRD2 dopamine receptor genotype, linkage disequilibrium, and alcoholism in American Indians and other populations. Alcohol Clin Exp Res (1993) 1.01
Single nucleotide polymorphisms in ANKK1 and the dopamine D2 receptor gene affect cognitive outcome shortly after traumatic brain injury: a replication and extension study. Brain Inj (2008) 1.01
Gender and environmental enrichment impact dopamine transporter expression after experimental traumatic brain injury. Exp Neurol (2005) 0.99
Association of COMT Val158Met genotype with executive functioning following traumatic brain injury. J Neuropsychiatry Clin Neurosci (2005) 0.99
Persistent symptoms in mild to moderate traumatic brain injury associated with executive dysfunction. J Clin Exp Neuropsychol (2010) 0.98
Traumatic brain injury reduces dopamine transporter protein expression in the rat frontal cortex. Neuroreport (2002) 0.98
Chronic methylphenidate treatment enhances striatal dopamine neurotransmission after experimental traumatic brain injury. J Neurochem (2008) 0.97
Tyrosine hydroxylase, but not dopamine beta-hydroxylase, is increased in rat frontal cortex after traumatic brain injury. Neuroreport (2001) 0.97
Glasgow Coma Scale score, mortality, and functional outcome in head-injured patients. J Trauma (2004) 0.97
Dopamine D2 receptor dimers in human and rat brain. FEBS Lett (1998) 0.94
Effect of the dopamine D2 receptor T allele on response latency after mild traumatic brain injury. Am J Psychiatry (2005) 0.94
Examining moderators of cognitive recovery trajectories after moderate to severe traumatic brain injury. Arch Phys Med Rehabil (2008) 0.92
Comparison of the predictive power of socio-economic variables, severity of injury and age on long-term outcome of traumatic brain injury: sample-specific variables versus factors as predictors. Brain Inj (2002) 0.92
The ANKK1 kinase gene and psychiatric disorders. Neurotox Res (2009) 0.91
Executive function and self-awareness of "real-world" behavior and attention deficits following traumatic brain injury. J Head Trauma Rehabil (2005) 0.89
Prediction of community integration and vocational outcome 2-5 years after traumatic brain injury rehabilitation in Australia. Brain Inj (1999) 0.89
Construct validity of various verbal and visual memory tests. J Clin Exp Neuropsychol (1995) 0.88
Short term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophrenia. Schizophr Res (2010) 0.86
Persistent hypogonadism influences estradiol synthesis, cognition and outcome in males after severe TBI. Brain Inj (2012) 0.86
Sex and genetic associations with cerebrospinal fluid dopamine and metabolite production after severe traumatic brain injury. J Neurosurg (2007) 0.86
A Rehabilomics focused perspective on molecular mechanisms underlying neurological injury, complications, and recovery after severe TBI. Pathophysiology (2012) 0.86
Polymorphisms in genes modulating the dopamine system: do they inf luence outcome and response to medication after traumatic brain injury? J Head Trauma Rehabil (2009) 0.85
TBI translational rehabilitation research in the 21st Century: exploring a Rehabilomics research model. Eur J Phys Rehabil Med (2010) 0.85
Variation in the BDNF gene interacts with age to predict mortality in a prospective, longitudinal cohort with severe TBI. Neurorehabil Neural Repair (2014) 0.84
Association study of three polymorphisms in the dopamine D2 receptor gene and schizophrenia in the Russian population. Schizophr Res (2008) 0.84
The influence of genetic variants on striatal dopamine transporter and D2 receptor binding after TBI. J Cereb Blood Flow Metab (2014) 0.83
Association of KIBRA rs17070145 polymorphism and episodic memory in individuals with severe TBI. Brain Inj (2012) 0.82
The sooner patients begin neurorehabilitation, the better their functional outcome. Brain Inj (2013) 0.81
Variants of SLC6A4 in depression risk following severe TBI. Brain Inj (2013) 0.81
INCOG guidelines for cognitive rehabilitation following traumatic brain injury: methods and overview. J Head Trauma Rehabil (2014) 0.79
PharmGKB summary: dopamine receptor D2. Pharmacogenet Genomics (2011) 0.78
Changes in dopamine transporter expression in the midbrain following traumatic brain injury: an immunohistochemical and in situ hybridization study in a mouse model. Neurol Res (2014) 0.78
The A1 allele of the D2 dopamine receptor gene is associated with high dopamine transporter density in detoxified alcoholics. Alcohol Alcohol (2001) 0.78
COMT Val158Met and cognitive and functional outcomes after traumatic brain injury. J Neurotrauma (2014) 0.77
Effect of COMT Val158Met genotype on attention and response to methylphenidate following traumatic brain injury. Brain Inj (2013) 0.77
Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet (2005) 4.91
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A (2010) 4.30
Interpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiers. PLoS Genet (2009) 4.22
Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81
IL-1β associations with posttraumatic epilepsy development: a genetics and biomarker cohort study. Epilepsia (2014) 2.59
Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. Am J Hum Genet (2004) 2.58
Meta-analysis of genome scans of age-related macular degeneration. Hum Mol Genet (2005) 2.34
Effect of hyperventilation on extracellular concentrations of glutamate, lactate, pyruvate, and local cerebral blood flow in patients with severe traumatic brain injury. Crit Care Med (2002) 2.21
Neurostimulation for traumatic brain injury. J Neurosurg (2014) 2.10
Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT). JAMA (2012) 2.06
Haptoglobin genotype and functional outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg (2013) 2.05
Blast exposure in rats with body shielding is characterized primarily by diffuse axonal injury. J Neurotrauma (2011) 1.71
Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis. Neurosci Biobehav Rev (2009) 1.57
Polynitroxylated pegylated hemoglobin: a novel neuroprotective hemoglobin for acute volume-limited fluid resuscitation after combined traumatic brain injury and hemorrhagic hypotension in mice. Crit Care Med (2011) 1.54
Survival without brain damage after clinical death of 60-120 mins in dogs using suspended animation by profound hypothermia. Crit Care Med (2003) 1.52
Attenuation of working memory and spatial acquisition deficits after a delayed and chronic bromocriptine treatment regimen in rats subjected to traumatic brain injury by controlled cortical impact. J Neurotrauma (2002) 1.47
Interleukin 6 and apolipoprotein E as predictors of acute brain dysfunction and survival in critical care patients. Am J Crit Care (2014) 1.42
Identification of a rare coding variant in complement 3 associated with age-related macular degeneration. Nat Genet (2013) 1.39
Concussion in sports: postconcussive activity levels, symptoms, and neurocognitive performance. J Athl Train (2008) 1.38
Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury. J Cereb Blood Flow Metab (2006) 1.37
Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: diagnosis, prognosis, probing mechanisms, and therapeutic decision making. Curr Opin Crit Care (2008) 1.34
Autophagy is increased after traumatic brain injury in mice and is partially inhibited by the antioxidant gamma-glutamylcysteinyl ethyl ester. J Cereb Blood Flow Metab (2007) 1.33
Pseudocholinesterase deficiency: a comprehensive review of genetic, acquired, and drug influences. AANA J (2010) 1.33
Neuroprotective, neuroplastic, and neurobehavioral effects of daily treatment with levetiracetam in experimental traumatic brain injury. Neurorehabil Neural Repair (2013) 1.30
Acute treatment with the 5-HT(1A) receptor agonist 8-OH-DPAT and chronic environmental enrichment confer neurobehavioral benefit after experimental brain trauma. Behav Brain Res (2006) 1.29
Experimental model of pediatric asphyxial cardiopulmonary arrest in rats. Pediatr Crit Care Med (2004) 1.24
Evaluation of estrous cycle stage and gender on behavioral outcome after experimental traumatic brain injury. Brain Res (2004) 1.24
C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes. PLoS One (2008) 1.22
Bromocriptine reduces lipid peroxidation and enhances spatial learning and hippocampal neuron survival in a rodent model of focal brain trauma. J Neurotrauma (2004) 1.19
Comparison of seven anesthetic agents on outcome after experimental traumatic brain injury in adult, male rats. J Neurotrauma (2006) 1.16
Mitogen-activated protein kinase inhibition in traumatic brain injury: in vitro and in vivo effects. J Cereb Blood Flow Metab (2002) 1.15
The therapeutic efficacy conferred by the 5-HT(1A) receptor agonist 8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) after experimental traumatic brain injury is not mediated by concomitant hypothermia. J Neurotrauma (2004) 1.15
A tale of two genotypes: consistency between two high-throughput genotyping centers. Genome Res (2002) 1.14
Intervention with environmental enrichment after experimental brain trauma enhances cognitive recovery in male but not female rats. Neurosci Lett (2002) 1.13
The high affinity peripheral benzodiazepine receptor ligand DAA1106 binds specifically to microglia in a rat model of traumatic brain injury: implications for PET imaging. Exp Neurol (2007) 1.12
Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype. Int J Epidemiol (2012) 1.12
Isoflurane exerts neuroprotective actions at or near the time of severe traumatic brain injury. Brain Res (2006) 1.12
Changes in expression of amyloid precursor protein and interleukin-1beta after experimental traumatic brain injury in rats. J Neurotrauma (2002) 1.11
Resveratrol attenuates behavioral impairments and reduces cortical and hippocampal loss in a rat controlled cortical impact model of traumatic brain injury. J Neurotrauma (2010) 1.10
Treating learning impairments improves memory performance in multiple sclerosis: a randomized clinical trial. Mult Scler (2005) 1.07
Acute serum hormone levels: characterization and prognosis after severe traumatic brain injury. J Neurotrauma (2011) 1.07
Local administration of the poly(ADP-ribose) polymerase inhibitor INO-1001 prevents NAD+ depletion and improves water maze performance after traumatic brain injury in mice. J Neurotrauma (2007) 1.07
A dual role for poly-ADP-ribosylation in spatial memory acquisition after traumatic brain injury in mice involving NAD+ depletion and ribosylation of 14-3-3gamma. J Neurochem (2003) 1.07
Immunohistochemical analysis of histone H3 acetylation and methylation--evidence for altered epigenetic signaling following traumatic brain injury in immature rats. Brain Res (2006) 1.06
Differential effects of single versus multiple administrations of haloperidol and risperidone on functional outcome after experimental brain trauma. Crit Care Med (2007) 1.05
Protective effects of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin against traumatic brain injury-induced cognitive deficits and neuropathology in adult male rats. Neurosci Lett (2002) 1.04
Simvastatin therapy prevents brain trauma-induced increases in beta-amyloid peptide levels. Ann Neurol (2009) 1.03
Hemorrhagic shock after experimental traumatic brain injury in mice: effect on neuronal death. J Neurotrauma (2009) 1.03
Delayed increase of tyrosine hydroxylase expression in rat nigrostriatal system after traumatic brain injury. Brain Res (2006) 1.03
Chronic Inflammation After Severe Traumatic Brain Injury: Characterization and Associations With Outcome at 6 and 12 Months Postinjury. J Head Trauma Rehabil (2015) 1.01
Time dependent alterations in dopamine tissue levels and metabolism after experimental traumatic brain injury in rats. Neurosci Lett (2004) 1.00
Resuscitation of traumatic brain injury and hemorrhagic shock with polynitroxylated albumin, hextend, hypertonic saline, and lactated Ringer's: Effects on acute hemodynamics, survival, and neuronal death in mice. J Neurotrauma (2009) 1.00
Gender and environmental enrichment impact dopamine transporter expression after experimental traumatic brain injury. Exp Neurol (2005) 0.99
Screening of biochemical and molecular mechanisms of secondary injury and repair in the brain after experimental blast-induced traumatic brain injury in rats. J Neurotrauma (2013) 0.99
Cerebral blood flow at one year after controlled cortical impact in rats: assessment by magnetic resonance imaging. J Neurotrauma (2002) 0.99
Traumatic brain injury reduces dopamine transporter protein expression in the rat frontal cortex. Neuroreport (2002) 0.98
Acute systemic administration of interleukin-10 suppresses the beneficial effects of moderate hypothermia following traumatic brain injury in rats. Brain Res (2002) 0.98
Gender associations with chronic methylphenidate treatment and behavioral performance following experimental traumatic brain injury. Behav Brain Res (2007) 0.98
Analysis of CHEK2 gene for ovarian cancer susceptibility. Gynecol Oncol (2004) 0.97
Chronic methylphenidate treatment enhances striatal dopamine neurotransmission after experimental traumatic brain injury. J Neurochem (2008) 0.97
Microarray technology applied to the complex disorder of preeclampsia. J Obstet Gynecol Neonatal Nurs (2008) 0.96
Group-based trajectory analysis applications for prognostic biomarker model development in severe TBI: a practical example. J Neurotrauma (2013) 0.94
Trajectory analysis of serum biomarker concentrations facilitates outcome prediction after pediatric traumatic and hypoxemic brain injury. Dev Neurosci (2010) 0.94
Docosahexaenoic acid reduces ER stress and abnormal protein accumulation and improves neuronal function following traumatic brain injury. J Neurosci (2014) 0.93
YKL-40 expression in traumatic brain injury: an initial analysis. J Neurotrauma (2010) 0.93
Neuroglobin genetic polymorphisms and their relationship to functional outcomes after traumatic brain injury. J Neurotrauma (2010) 0.93
The predictive validity of a brief inpatient neuropsychologic battery for persons with traumatic brain injury. Arch Phys Med Rehabil (2008) 0.93
Transgenic mice that overexpress the anti-apoptotic Bcl-2 protein have improved histological outcome but unchanged behavioral outcome after traumatic brain injury. Brain Res (2006) 0.92
boc-Aspartyl(OMe)-fluoromethylketone attenuates mitochondrial release of cytochrome c and delays brain tissue loss after traumatic brain injury in rats. J Cereb Blood Flow Metab (2006) 0.92
S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injury. J Neurotrauma (2013) 0.92
BCL2 genotypes: functional and neurobehavioral outcomes after severe traumatic brain injury. J Neurotrauma (2010) 0.91
Biologic and plastic effects of experimental traumatic brain injury treatment paradigms and their relevance to clinical rehabilitation. PM R (2011) 0.91
Apolipoprotein E4 allele presence and functional outcome after severe traumatic brain injury. J Neurotrauma (2007) 0.91
The potential for bio-mediators and biomarkers in pediatric traumatic brain injury and neurocritical care. Front Neurol (2013) 0.91
Gel-based hippocampal proteomic analysis 2 weeks following traumatic brain injury to immature rats using controlled cortical impact. Dev Neurosci (2006) 0.90
Expression of protein phosphatase 2B (calcineurin) subunit A isoforms in rat hippocampus after traumatic brain injury. J Neurotrauma (2010) 0.90
Traumatic brain injury reduces striatal tyrosine hydroxylase activity and potassium-evoked dopamine release in rats. Brain Res (2010) 0.90
Adenosine A1 receptor gene variants associated with post-traumatic seizures after severe TBI. Epilepsy Res (2010) 0.90
Disruption of Bax protein prevents neuronal cell death but produces cognitive impairment in mice following traumatic brain injury. J Neurotrauma (2008) 0.90
Early trajectory of psychiatric symptoms after traumatic brain injury: relationship to patient and injury characteristics. J Neurotrauma (2014) 0.89
Morris water maze function and histologic characterization of two age-at-injury experimental models of controlled cortical impact in the immature rat. Childs Nerv Syst (2012) 0.89
A novel multicenter preclinical drug screening and biomarker consortium for experimental traumatic brain injury: operation brain trauma therapy. J Trauma (2011) 0.89
Administration of adenosine receptor agonists or antagonists after controlled cortical impact in mice: effects on function and histopathology. Brain Res (2002) 0.89
Severe brief pressure-controlled hemorrhagic shock after traumatic brain injury exacerbates functional deficits and long-term neuropathological damage in mice. J Neurotrauma (2012) 0.89
Hemorrhagic shock shifts the serum cytokine profile from pro- to anti-inflammatory after experimental traumatic brain injury in mice. J Neurotrauma (2014) 0.89
Brief induced hypothermia improves outcome after asphyxial cardiopulmonary arrest in juvenile rats. Dev Neurosci (2005) 0.88
Effects of post-injury hypothermia and nerve growth factor infusion on antioxidant enzyme activity in the rat: implications for clinical therapies. J Neurochem (2004) 0.88
Gene expression in first trimester preeclampsia placenta. Biol Res Nurs (2010) 0.88
Mapping of phospholipids by MALDI imaging (MALDI-MSI): realities and expectations. Chem Phys Lipids (2012) 0.87
Genetic disruption of cyclooxygenase-2 does not improve histological or behavioral outcome after traumatic brain injury in mice. J Neurosci Res (2008) 0.87
Corpus callosum integrity and neuropsychological performance after traumatic brain injury: a diffusion tensor imaging study. J Head Trauma Rehabil (2014) 0.86
The dopamine and cAMP regulated phosphoprotein, 32 kDa (DARPP-32) signaling pathway: a novel therapeutic target in traumatic brain injury. Exp Neurol (2011) 0.86
CSF Bcl-2 and cytochrome C temporal profiles in outcome prediction for adults with severe TBI. J Cereb Blood Flow Metab (2011) 0.86
Sex and genetic associations with cerebrospinal fluid dopamine and metabolite production after severe traumatic brain injury. J Neurosurg (2007) 0.86
Persistent hypogonadism influences estradiol synthesis, cognition and outcome in males after severe TBI. Brain Inj (2012) 0.86